Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G M Ross

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
Proceedings of the National Academy of Sciences of the United States of America|October 10, 1995
A nerve growth factor peptide retards seizure development and inhibits neuronal sprouting in a rat model of epilepsyK Rashid, C E Van der Zee, G M Ross, et al.
European Journal of Pharmacology|March 28, 1996
Modulation of brain catecholamine absorbing proteins by dopaminergic agentsP I Modi, A Kashyap, V D Nair, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 21, 1999
Characterization of antiallodynic actions of ALE-0540, a novel nerve growth factor receptor antagonist, in the ratJ B Owolabi, G Rizkalla, A Tehim, et al.
Journal of Neurochemistry|August 3, 2001
The binding of zinc and copper ions to nerve growth factor is differentially affected by pH: implications for cerebral acidosisG M Ross, I L Shamovsky, S B Woo, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
Proceedings of the National Academy of Sciences of the United States of America|October 10, 1995
A nerve growth factor peptide retards seizure development and inhibits neuronal sprouting in a rat model of epilepsyK Rashid, C E Van der Zee, G M Ross, et al.
European Journal of Pharmacology|March 28, 1996
Modulation of brain catecholamine absorbing proteins by dopaminergic agentsP I Modi, A Kashyap, V D Nair, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 21, 1999
Characterization of antiallodynic actions of ALE-0540, a novel nerve growth factor receptor antagonist, in the ratJ B Owolabi, G Rizkalla, A Tehim, et al.
Journal of Neurochemistry|August 3, 2001
The binding of zinc and copper ions to nerve growth factor is differentially affected by pH: implications for cerebral acidosisG M Ross, I L Shamovsky, S B Woo, et al.
Pageof 5